Related Experiment Video
Updated: Sep 23, 2026
Osteopathic Manipulative Treatment as a Useful Adjunctive Tool for Pneumonia
Published on: May 6, 2014
Novel approaches to the treatment of pneumonia
Mario Cazzola1, Maria G Matera, Clive P Page
1Cardarelli Hospital, Department of Respiratory Medicine, Unit of Pneumology and Allergology, Via del Parco Margherita 24, 80121 Napoli, Italy. mcazzola@qubisoft.it
Abstract:
As the prevalence of resistance to multiple antibiotics increases it is progressively more difficult to treat pneumonia in hospitalized patients. Therefore, anti-infectious agents that have new modes of action are needed urgently. Recent advances in DNA sequencing technology make it possible to elucidate the sequences of the entire genomes of pathogenic bacteria. This allows many novel, non-traditional targets for therapeutic intervention to be identified, such as those involved in disease pathogenesis, and in adaptation and growth at sites of infection. In the past few years, inhibitors of new bacterial targets have been developed, including inhibitors of genes that are required for either virulence or pathogenesis. The challenge is to optimize and develop these agents to provide novel approaches to the treatment of pneumonia in hospitalized patients.
Insights
The rise in antibiotic resistance makes treating hospital-acquired pneumonia difficult. New anti-infective drugs targeting novel bacterial mechanisms are urgently needed for effective pneumonia treatment.
Area of Science:
- Microbiology
- Genomics
- Pharmacology
Background:
- Increasing antibiotic resistance poses a significant challenge for treating hospital-acquired pneumonia.
- Novel anti-infective agents with new mechanisms of action are urgently required.
Purpose of the Study:
- To explore novel therapeutic targets for pneumonia treatment by leveraging advances in bacterial genomics.
- To identify and develop new anti-infective agents targeting bacterial pathogenesis, adaptation, and growth.
Main Methods:
- Utilizing advanced DNA sequencing to analyze complete pathogenic bacterial genomes.
- Identifying novel, non-traditional therapeutic targets involved in bacterial virulence and pathogenesis.
- Developing inhibitors for newly identified bacterial targets.
Main Results:
- Genomic sequencing has revealed numerous novel targets for therapeutic intervention in pathogenic bacteria.
- Inhibitors targeting bacterial virulence and pathogenesis genes have been developed.
- Progress has been made in identifying new strategies for combating pneumonia.
Conclusions:
- Advances in genomics offer new avenues for discovering antibacterial drug targets.
- Developing novel anti-infective agents targeting these targets is crucial for overcoming antibiotic resistance in pneumonia.
- Further optimization and development of these agents are necessary for clinical application in treating hospitalized patients with pneumonia.
Related Concept Videos
01:28Pneumonia IV: Management
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
01:30Pneumonia V: Nursing management and Prevention
The nurse must practice strict medical asepsis and adhere to infection control guidelines to minimize healthcare-associated infections.
Enhance airway patency
Position the patient correctly to facilitate drainage of the affected lung segments. Manual or mechanical percussion and vibration can also be employed.
01:14Atypical Pneumonia
01:30Pneumonia III: Complications and Assessment
01:29Pneumonia I: Introduction
01:30Pneumonia I: Introduction
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...